Literature DB >> 34637090

Long non-coding RNA SOS1-IT1 promotes endometrial cancer progression by regulating hypoxia signaling pathway.

Hongyang Liu1, Junhu Wan2, Quanling Feng2, Jingyu Li3, Jun Liu4, Shihong Cui5.   

Abstract

Endometrial cancer (EC) is one of the most common types of gynecological cancer. Hypoxia is an important clinical feature and regulates various tumor processes. However, the prognostic value of hypoxia-related lncRNA in EC remains to be further elucidated. Here, we aimed to characterize the molecular features of EC by the development of a classification system based on the expression profile of hypoxia-related lncRNA. Based on univariate Cox regression analysis, we identified 17 hypoxia-related lncRNAs significantly associated with overall survival. Next, the least absolute shrinkage and selection operator Cox regression model was utilized to construct a multigene signature in the TCGA EC cohort. The risk score was confirmed as an independent predictor for overall survival in multivariate Cox regression analysis and receiver operating characteristic (ROC) curve analysis. Besides, the survival time of EC patients in different risk group was significantly correlated to clinicopathologic factors, such as age, stage and grade. Furthermore, hypoxia-related lncRNA associated with the high-risk group were involved in various aspects of the malignant progression of EC via Gene Ontology, Kyoto Encyclopedia of Genes and Genomes pathway, and Gene Set Enrichment Analysis. Moreover, the risk score was closely correlated to immunotherapy response, microsatellite instability and tumor mutation burden. Finally, we select one hypoxia-related lncRNA SOS1-IT1 to validate its role in hypoxia and EC progression. Interestingly, we found SOS1-IT1 was overexpressed in tumor tissues, and closely correlated with clinicopathological parameters of EC. The expression level of SOS1-IT1 was significantly increased under hypoxia condition. Additionally, the important hypoxia regulatory factor HIF-1α can directly bind SOS1-IT1 promoter region, and affect its expression level. In summary, this study established a new EC classification based on the hypoxia-related lncRNA signature, thereby provide a novel sight to understand the potential mechanism of human EC development.
© 2021. The International CCN Society.

Entities:  

Keywords:  Endometrial cancer; Hypoxia; Prognostic prediction; SOS1-IT1; lncRNA

Year:  2021        PMID: 34637090      PMCID: PMC8891412          DOI: 10.1007/s12079-021-00651-1

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.908


  35 in total

Review 1.  HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations.

Authors:  Gregg L Semenza
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  Lysine crotonylation is involved in hepatocellular carcinoma progression.

Authors:  Junhu Wan; Hongyang Liu; Liang Ming
Journal:  Biomed Pharmacother       Date:  2019-01-09       Impact factor: 6.529

Review 3.  HIF-1 in cancer therapy: two decade long story of a transcription factor.

Authors:  Sourabh Soni; Yogendra S Padwad
Journal:  Acta Oncol       Date:  2017-04       Impact factor: 4.089

Review 4.  Management of Endometrial Cancer: A Review.

Authors:  Vanita Suri; Aashima Arora
Journal:  Rev Recent Clin Trials       Date:  2015

Review 5.  Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination.

Authors:  Celine Boutros; Ahmad Tarhini; Emilie Routier; Olivier Lambotte; Francois Leroy Ladurie; Franck Carbonnel; Hassane Izzeddine; Aurelien Marabelle; Stephane Champiat; Armandine Berdelou; Emilie Lanoy; Matthieu Texier; Cristina Libenciuc; Alexander M M Eggermont; Jean-Charles Soria; Christine Mateus; Caroline Robert
Journal:  Nat Rev Clin Oncol       Date:  2016-05-04       Impact factor: 66.675

6.  HIF2-Induced Long Noncoding RNA RAB11B-AS1 Promotes Hypoxia-Mediated Angiogenesis and Breast Cancer Metastasis.

Authors:  Yanling Niu; Lei Bao; Yan Chen; Chenliang Wang; Maowu Luo; Bo Zhang; Mi Zhou; Jennifer E Wang; Yisheng V Fang; Ashwani Kumar; Chao Xing; Yingfei Wang; Weibo Luo
Journal:  Cancer Res       Date:  2020-01-03       Impact factor: 12.701

Review 7.  Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.

Authors:  Farnaz Hajizadeh; Isobel Okoye; Maryam Esmaily; Mitra Ghasemi Chaleshtari; Ali Masjedi; Gholamreza Azizi; Mahzad Irandoust; Ghasem Ghalamfarsa; Farhad Jadidi-Niaragh
Journal:  Life Sci       Date:  2019-10-14       Impact factor: 5.037

Review 8.  Advances in Hypoxia-Inducible Factor Biology.

Authors:  Hani Choudhry; Adrian L Harris
Journal:  Cell Metab       Date:  2017-11-09       Impact factor: 27.287

9.  Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes.

Authors:  Na Li; Xianquan Zhan
Journal:  EPMA J       Date:  2020-05-28       Impact factor: 6.543

Review 10.  The roles of long noncoding RNAs in breast cancer metastasis.

Authors:  Lingxia Liu; Yu Zhang; Jun Lu
Journal:  Cell Death Dis       Date:  2020-09-14       Impact factor: 8.469

View more
  1 in total

1.  Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer.

Authors:  Jingchao Liu; Wei Zhang; Jiawen Wang; Zhengtong Lv; Haoran Xia; Zhipeng Zhang; Yaoguang Zhang; Jianye Wang
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-22       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.